Mindfulness Self-Compassion Intervention Versus a Cognitive-Behavioral Intervention to Improve Self-care in Chronic Pain

May 1, 2020 updated by: Angela Palao, Instituto de Investigación Hospital Universitario La Paz

"Pilot Study to Compare the Effectiveness of a Mindfulness Self-Compassion Intervention Versus a Cognitive-Behavioural Intervention to Improve Self-care and Quality of Life in a Chronic Pain Sample"

Approximately 10-23% of people suffer from chronic pain in our country. Chronic pain is associated with emotional distress (anxiety and depression), physical and social impairment and reduction of quality of life in patients who suffer from this condition.

Self-Compassion is a useful attitude in order to regulate emotions, to be able to accept the experience that one is going through and to improve self-care in general population. Cognitive-behavioral programs (CBT) have already demonstrated that they are effective in order to reduce catastrophizing and passive coping with pain. However, effects of Mindful Self-Compassion interventions (based on mindfulness skills but not only) on chronic pain condition are still unknown.

The investigator's principal hypothesis is: MSC program will be, at least, as effective as CBT program in order to improve quality of life, self-compassion, self-care and acceptance capacity; and as effective as CBT to reduce catastrophizing, anxiety and depression in a chronic pain patients sample.

Moreover, investigators also hypothesize that MSC program will be, at least, as effective as CBT program in order to maintain the achieved benefits in a 6 months follow-up.

Investigators will conduct a Randomized Controlled Trial with two treatment arms in a chronic pain sample of patients of Hospital Universitario La Paz, Madrid.

After all recollection of data is done, investigators will conduct statistic analysis in order to accept or refuse our hypothesis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Approximately 10-23% of people suffer from chronic pain in our country. Chronic pain is associated with emotional distress (anxiety and depression), physical and social impairment and reduction of quality of life in patients who suffer from this condition.

Recent studies have elucidated that some conditions are clearly correlated with chronic pain, and could explain emotional distress and impairment in these patients. Such conditions are: attention bias to pain, cognitive inflexibility, fear avoidance, catastrophizing, passive coping with pain and no acceptance.

Recent meta-analysis suggest that Mindfulness-based interventions reduce anxiety and pain interference in daily life in patients with chronic pain. They do so through mechanisms that improve capacity of acceptance (whatever the experience is) and reduce catastrophizing. Self-Compassion is a useful attitude in order to regulate emotions, to be able to accept the experience that one is going through and to improve self-care in general population. Cognitive-behavioral programs (CBT) have already demonstrated that they are effective in order to reduce catastrophizing and passive coping with pain. However, effects of Mindful Self-Compassion interventions (based on mindfulness skills but not only) on chronic pain condition are still unknown.

Neff and Germer have developed a specific program to enhance self-compassion named Mindful Self-Compassion (MSC) that could be helpful to people with clinical problems. In spite of promising results of this interventions based on acceptation and self-compassion, its effectiveness on chronic pain conditions remains still unclear.

Investigator's principal hypothesis is: MSC program will be, at least, as effective as CBT program in order to improve quality of life, self-compassion, self-care and acceptance capacity; and as effective as CBT to reduce catastrophizing, anxiety and depression in a chronic pain patients sample.

Moreover, investigators also hypothesize that MSC program will be, at least, as effective as CBT program in order to maintain the achieved benefits in a 6 months follow-up.

Investigators will conduct a Randomized Controlled Trial with two treatment arms in a chronic pain sample of patients of Hospital Universitario La Paz, Madrid.

Both interventions will have 8 sessions, weekly frequency, duration of 2 hours and a half per session, and both programs will be conducted by clinical experts.

Investigators will asses levels of anxiety, depression, catastrophizing, pain interference, pain intensity, self-compassion and quality of life at the beginning of the intervention, at the end of the intervention, and a 6 months follow-up. Investigators also will administer a socio-demographic questionnaire at the beginning of the intervention to collect data about age, gender and pain characteristics.

After all recollection of data is done, investigators will conduct statistic analysis in order to accept or refuse their hypothesis.

Study Type

Interventional

Enrollment (Actual)

159

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28046
        • Hospital Universitario La Paz.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Older than 18 years old.
  • Being in treatment in the Chronic Pain Unit at Hospital Universitario La Paz because of having a chronic pain of more than 3 months of duration, no matter the aetiology.
  • Capable of understanding and giving his or her written informed consent.
  • Significant levels of distress related to the pain at the beginning of treatment, assessed by clinical interview and HADS (HADS-A or HADS-D > or = 8).
  • Patients that meet criteria for Mixed Adaptive Disorder, mild to moderate Depressive Disorder or Dysthymia, assessed by clinical interview conducted by a psychiatry of the Chronic Pain Unit or Mental Health Center.

Exclusion Criteria:

  • Intelectual disability or cognitive impairment or dementia.
  • Insufficient knowledge of the language to understand and participate on the intervention program.
  • Serious mental illness in acute state at the moment of the beginning of the intervention.
  • Substance abuse in the last 6 months.
  • Autolytic ideas at the moment of the assessment.
  • Previous training in mindfulness or CBT techniques.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness Self-Compassion Intervention MSC

Mindfulness Self-Compassion (MSC) is a standardized program to increase self-compassion. It has been developed by Neff and Germer. The structure of the program is similar to de Mindfulness-Based Stress Reduction program (MBSR), with duration of sessions between 2 and 2 hours and a half. The frequency of the sessions is one per week for 8 weeks, with practical and experiential exercices in sessions and between sessions.

The MSC program focuses primary on helping patients to develop self-compassion, and it includes Mindfulness just as a secondary component.

The MSC program will be conducted by a clinician trained in this specific program.

Mindfulness and Self-Compassion training
Active Comparator: Cognitive-Behavioural Intervention CBT

It has been adapted a Cognitive-Behavioural Intervention for Chronic Pain by Moix and Kovacs. Our program will have 8 sessions, with duration of sessions between 2 and 2 hours and a half. The frequency of the sessions is one per week for 8 weeks, with homework between sessions.

During these 8 sessions we will train the following techniques: psychoeducation about pain, relaxation training, cognitive restructuring training, solving problem training, psychoeducation about emotions, interpersonal skills and time organization.

Cognitive-behavioural techniques training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Compassion
Time Frame: Up to 8 weeks
Self-Compassion Scale (SCS, long version). Self-compassion and Self-care. Self-kindness, Common Humanity and Mindfulness. 26 items. Total score and 3 sub-scores from 1 to 5. Likert scale from 1 to 5.
Up to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptance
Time Frame: Up to 8 weeks
Chronic Pain Acceptance Questionnaire (CPAQ). 2 factors: Activity engagement and Pain willingness.
Up to 8 weeks
Acceptance
Time Frame: In a 6 months follow-up
Chronic Pain Acceptance Questionnaire (CPAQ). 2 factors: Activity engagement and Pain willingness.
In a 6 months follow-up
Acceptance
Time Frame: Day 1 of the intervention
Chronic Pain Acceptance Questionnaire (CPAQ). 2 factors: Activity engagement and Pain willingness.
Day 1 of the intervention
Pain Interference
Time Frame: Up to 8 weeks
Pain interference in daily life. Brief Pain Inventory (BPI): pain intensity and impact of pain in daily life. Investigators will use Impact in daily life sub-scale (7 items). Scores are from 0 to10.
Up to 8 weeks
Pain Interference
Time Frame: In a 6 months follow-up
Pain interference in daily life. Brief Pain Inventory (BPI): pain intensity and impact of pain in daily life. Investigators will use Impact in daily life sub-scale (7 items). Scores are from 0 to10.
In a 6 months follow-up
Pain Interference
Time Frame: Day 1 of the intervention
Pain interference in daily life. Brief Pain Inventory (BPI): pain intensity and impact of pain in daily life. Investigators will use Impact in daily life sub-scale (7 items). Scores are from 0 to10.
Day 1 of the intervention
Pain Intensity
Time Frame: Up to 8 weeks.
Analogical Visual Scale. From 0 to 10 scores.
Up to 8 weeks.
Pain Intensity
Time Frame: In a 6 months follow-up
Analogical Visual Scale. From 0 to 10 scores.
In a 6 months follow-up
Pain Intensity
Time Frame: Day 1 of the intervention
Analogical Visual Scale. From 0 to 10 scores.
Day 1 of the intervention
Catastrophising
Time Frame: Up to 8 weeks.
Pain Catastrophising Scale (PCS). Rumination, magnification of consequences and hopelessness. 13 items, self-administered.
Up to 8 weeks.
Catastrophising
Time Frame: In a 6 months follow-up
Pain Catastrophising Scale (PCS). Rumination, magnification of consequences and hopelessness. 13 items, self-administered.
In a 6 months follow-up
Catastrophising
Time Frame: Day 1 of the intervention
Pain Catastrophising Scale (PCS). Rumination, magnification of consequences and hopelessness. 13 items, self-administered.
Day 1 of the intervention
Quality of life
Time Frame: Up to 8 weeks.
Health-Related Quality Of Life, Short Form (SF-36). 36 items. 8 sub-scores, no total score. Physical function, physical role, body pain, general state of health, vitality, social function, emotional role and mental health.
Up to 8 weeks.
Quality of life
Time Frame: In a 6 months follow-up
Health-Related Quality Of Life, Short Form (SF-36). 36 items. 8 sub-scores, no total score. Physical function, physical role, body pain, general state of health, vitality, social function, emotional role and mental health.
In a 6 months follow-up
Quality of life
Time Frame: Day 1 of the intervention
Health-Related Quality Of Life, Short Form (SF-36). 36 items. 8 sub-scores, no total score. Physical function, physical role, body pain, general state of health, vitality, social function, emotional role and mental health.
Day 1 of the intervention
Anxiety and Depression
Time Frame: Up to 8 weeks.
Levels of anxiety and depression. Symptomatology. Hospital Anxiety and Depression Scale (HADS). 14 items. 2 separated scores, 7 items each: anxiety and depression.
Up to 8 weeks.
Anxiety and Depression
Time Frame: In a 6 months follow-up
Levels of anxiety and depression. Symptomatology. Hospital Anxiety and Depression Scale (HADS). 14 items. 2 separated scores, 7 items each: anxiety and depression.
In a 6 months follow-up
Anxiety and Depression
Time Frame: Day 1 of the intervention
Levels of anxiety and depression. Symptomatology. Hospital Anxiety and Depression Scale (HADS). 14 items. 2 separated scores, 7 items each: anxiety and depression.
Day 1 of the intervention
Satisfaction with the treatment
Time Frame: Up to 8 weeks.
Satisfaction with the treatment (CRES-4). 4 questions. Scores from 0 to 300. The higher the punctuation, the higher satisfaction with treatment.
Up to 8 weeks.
Adherence to the treatment
Time Frame: Up to 8 weeks.
Adherence to the treatment (Number of sessions that one patient attends)
Up to 8 weeks.
Self-Compassion
Time Frame: In a 6 months follow-up
Self-Compassion Scale (SCS, long version). Self-compassion and Self-care. Self-kindness, Common Humanity and Mindfulness. 26 items. Total score and 3 sub-scores from 1 to 5. Likert scale from 1 to 5.
In a 6 months follow-up
Self-Compassion
Time Frame: Day 1 of the intervention
Self-Compassion Scale (SCS, long version). Self-compassion and Self-care. Self-kindness, Common Humanity and Mindfulness. 26 items. Total score and 3 sub-scores from 1 to 5. Likert scale from 1 to 5.
Day 1 of the intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socio- demographic Data: Number of visited doctors.
Time Frame: Day 1 of the intervention
Number of visited doctors in the last 3 months. Sociodemographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: Number of visits to emergency units.
Time Frame: Day 1 of the intervention
Number of visits to emergency units in the last 3 months. Sociodemographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: course of pain expectation.
Time Frame: Day 1 of the intervention
Course of pain that the patient expects (improvement, same condition, progressive worsening…) at the moment the intervention starts. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: psychiatric history.
Time Frame: Day 1 of the intervention
Psychiatric history: whether the patient has or has not a history of mental health services visits for some kind of mental disorder. Socio-demographic data questionnaire.
Day 1 of the intervention
Socio- demographic Data: type of pain.
Time Frame: Day 1 of the intervention
Type of pain: area of pain in the body, diagnosis related to pain made for patient's doctor. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: time since pain started.
Time Frame: Day 1 of the intervention
Time since the pain started: amount of time the patient has lived with pain. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: job status.
Time Frame: Day 1 of the intervention
Job status: whether the patient is student, employed, unemployed, retired, or has a pension because of his/her disability. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: family life.
Time Frame: Day 1 of the intervention
Family life: It is asked with whom the patient lives (couple, alone, kids, kids and couple…), if he/she has kids and if he/she lives with them. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: Marital Status
Time Frame: Day 1 of the intervention
Marital Status: whether the patient is single, married or in a couple, divorced, or widower. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: Gender
Time Frame: Day 1 of the intervention
Gender: Male or female. Socio-demographic data Questionnaire.
Day 1 of the intervention
Socio- demographic Data: Age
Time Frame: Day 1 of the intervention
Age of the patient. Socio-demographic data Questionnaire.
Day 1 of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Beatriz Rodríguez Vega, Hospital Universitario La Paz. Universidad Autónoma de Madrid.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2017

Primary Completion (Actual)

December 7, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

December 8, 2017

First Submitted That Met QC Criteria

December 28, 2017

First Posted (Actual)

December 29, 2017

Study Record Updates

Last Update Posted (Actual)

May 5, 2020

Last Update Submitted That Met QC Criteria

May 1, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on MSC

3
Subscribe